Enhanced neutrophil motility by granulocyte colony-stimulating factor: the role of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. 2006

Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
Department of Physiology, Osaka City University Graduate School of Medicine, Abenoku, Osaka, Japan.

The effect of granulocyte colony-stimulating factor (G-CSF) on human neutrophil motility was studied using videomicroscopy. Stimulation of neutrophils with G-CSF resulted in enhanced motility with morphological change and increased adherence. Enhanced neutrophil motility was detected within 3-5 min after G-CSF stimulation, reached a maximum at 10 min, and was sustained for approximately 35 min. The maximum migration rate was 84.4 +/- 2.9 microm/5 min. A study using the Boyden chamber method revealed that G-CSF-stimulated neutrophils exhibited random migration but not chemotaxis. Enhanced neutrophil motility and morphological change were inhibited by MEK [mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase] inhibitors (PD98059 and U0126), and a phosphatidylinositol 3-kinase (PI3K) inhibitor (wortmannin), but not by a p38 MAPK inhibitor (SB203580). These findings are consistent with the fact that G-CSF selectively activates MEK/ERK and PI3K, but not p38, in neutrophils. MEK/ERK activation was associated with G-CSF-induced redistribution of F-actin and phosphorylated myosin light chain. Enhanced neutrophil motility was observed even in the presence of neutralizing anti-CD18 antibody, which prevented cell adherence. These findings indicate that G-CSF induces human neutrophil migration via activation of MEK/ERK and PI3K.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016179 Granulocyte Colony-Stimulating Factor A glycoprotein of MW 25 kDa containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukemic myeloid cell lines. Colony-Stimulating Factor, Granulocyte,G-CSF,Myeloid Growth Factor,Colony Stimulating Factor, Granulocyte,Factor, Granulocyte Colony-Stimulating,Factor, Myeloid Growth,Granulocyte Colony Stimulating Factor,Growth Factor, Myeloid
D048049 Extracellular Signal-Regulated MAP Kinases A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS. ERK MAP Kinase,ERK MAP Kinases,Extracellular Signal-Regulated Kinase,Extracellular Signal-Regulated Kinases,Extracellular Signal-Regulated MAP Kinase,MAP Kinases, Extracellular Signal-Regulated,Extracellular Signal Regulated Kinase,Extracellular Signal Regulated Kinases,Extracellular Signal Regulated MAP Kinase,Extracellular Signal Regulated MAP Kinases,Kinase, ERK MAP,Kinase, Extracellular Signal-Regulated,Kinases, Extracellular Signal-Regulated,MAP Kinase, ERK,MAP Kinases, Extracellular Signal Regulated,Signal-Regulated Kinase, Extracellular

Related Publications

Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
April 2000, Journal of immunology (Baltimore, Md. : 1950),
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
December 2004, International journal of hematology,
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
December 1993, Experimental hematology,
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
November 2006, The journals of gerontology. Series A, Biological sciences and medical sciences,
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
July 2013, Oncology reports,
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
May 2001, Cellular signalling,
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
January 2014, PloS one,
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
April 2004, The Journal of investigative dermatology,
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
August 1999, The Journal of biological chemistry,
Mika Nakamae-Akahori, and Takayuki Kato, and Sayuri Masuda, and Erina Sakamoto, and Haruo Kutsuna, and Fumihiko Hato, and Yoshiki Nishizawa, and Masayuki Hino, and Seiichi Kitagawa
May 2010, American journal of hematology,
Copied contents to your clipboard!